“Certolizumab Pegol for the Treatment of Patients With Moderate-to-Severe Chronic Plaque Psoriasis: An Overview of 3 Randomized Controlled Trials”. 2018. SKIN The Journal of Cutaneous Medicine 2 (S1): S3. https://doi.org/10.25251/skin.2.supp.3.